{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:20:35Z","timestamp":1760833235351,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.nmd.2020.11.007","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T05:16:06Z","timestamp":1605762966000},"page":"52-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early onset neutral lipid storage disease with myopathy presenting as congenital hypotonia and hepatomegaly"],"prefix":"10.1016","volume":"31","author":[{"given":"Daniela","family":"Avila-Smirnow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Dur\u00e1n-Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Ovalle-Besa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Gejman-Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.11.007_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1209-z","article-title":"Neutral lipid storage disease with myopathy in China: a large multicentric cohort study","volume":"14","author":"Zhang","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.11.007_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0646-9","article-title":"Neutral lipid storage diseases: clinical\/genetic features and natural history in a large cohort of Italian patients","volume":"12","author":"Pennisi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.11.007_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2020.11.007_bib0004","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2013.08.008","article-title":"PNPLA2 mutation: a paediatric case with early onset but indolent course","volume":"23","author":"Perrin","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.11.007_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12881-018-0683-9","article-title":"Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy","volume":"19","author":"Zheng","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nmd.2020.11.007_bib0006","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2012.10.127","article-title":"Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene","volume":"430","author":"Fiorillo","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2020.11.007_bib0007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clineuro.2018.03.001","article-title":"Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China","volume":"168","author":"Tan","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2020.11.007_bib0008","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneurol.2011.2600","article-title":"A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy","volume":"69","author":"Ash","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2020.11.007_bib0009","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1212\/WNL.0000000000002999","article-title":"Clinical Reasoning: a 33-year-old man with cardiomyopathy and myopathy","volume":"87","author":"Foster","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.11.007_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nmd.2018.04.010","article-title":"Neutral lipid storage disease with myopathy: further phenotypic characterization of a rare PNPLA2 variant","volume":"28","author":"Latimer","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.11.007_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2010.04.004","article-title":"Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene","volume":"20","author":"Akman","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.11.007_bib0012","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nmd.2008.06.382","article-title":"Distal lipid storage myopathy due to PNPLA2 mutation","volume":"18","author":"Ohkuma","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.11.007_bib0013","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.11.007_bib0014","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.20869","article-title":"Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy","volume":"36","author":"Akiyama","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.11.007_bib0015","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00415-011-6055-4","article-title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene","volume":"258","author":"Reilich","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2020.11.007_bib0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2012.12.004","article-title":"Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study","volume":"108","author":"Lafor\u00eat","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.11.007_bib0017","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2008.10.081","article-title":"Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy","volume":"377","author":"Campagna","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2020.11.007_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.02.082","article-title":"Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease","volume":"210","author":"Muggenthaler","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nmd.2020.11.007_bib0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocn.2018.10.046","article-title":"Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis","volume":"58","author":"Garcia","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2020.11.007_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.113.300944","article-title":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the pnpla2 gene, causing neutral lipid storage disease with Myopathy","volume":"112","author":"Van De Weijer","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.nmd.2020.11.007_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.08.001","article-title":"Lipid storage myopathies: current treatments and future directions","volume":"72","author":"Vasiljevski","year":"2018","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.nmd.2020.11.007_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.nmd.2020.11.007_bib0023","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archneurol.2011.631","article-title":"Blocked muscle fat oxidation during exercise in neutral lipid storage disease","volume":"69","author":"Lafor\u00eat","year":"2012","journal-title":"Arch Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:40Z","timestamp":1760775040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620306726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0960896620306726"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.11.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early onset neutral lipid storage disease with myopathy presenting as congenital hypotonia and hepatomegaly","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}